In Vitro Diagnostics Market in India 2014

Published: Oct, 2014 | Pages: 128 | Publisher: Netscribes
Industry: Healthcare | Report Format: Electronic (PDF)

Netscribes' latest market research report titled In Vitro Diagnostics Market in India 2014 analyses the growth of the market due to improved technology and modern diagnostic tools which provides faster and accurate test results for the patients. The market can be segmented on the basis of the product type and the technology used. The technology market is sub-divided into the following sections such as immunochemistry, molecular diagnostics, hematology, coagulation, microbiology, biochemistry, urinalysis and blood gas and electrolyte. According to product type, the market can be further sub-divided into instruments and reagents. 

Driven by factors such as high patient population, rise in the number of hospitals and diagnostic labs and other factors, the IVD market is experiencing a developing phase. The main challenges the market is experiencing are faulty regulations and laboratory without accreditation. Trends such as automation, remote data acquisition and other factors are helping the market to grow. The market is dominated by private player followed by public players. Decentralized testing, increasing automated laboratories, increasing consolidation and demand for early detection of diseases will contribute towards the growth of the market in the following years

 Table of Contents
Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Aug 2013 - Jan 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Introduction
Slide 5: In Vitro Diagnostics Equipment - Overview 
Slide 6: In Vitro Diagnostics Equipment - Segmentation of the products
Slide 7: Value Chain of IVD 

Market Overview 
Slide 8: In Vitro Diagnostics Market - Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 9: In Vitro Diagnostics Market - Instruments, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e), Reagents, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 10: Immunochemistry - Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 11 : Immunochemistry - Instruments, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e), Reagents, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 12: Immunochemistry - Elisa Kits, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e), Rapid Tests, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 11: Biochemistry - Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 12: Biochemistry - Instruments, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e), Reagents, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 13: Hematology - Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 14: Hematology - Instruments, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e), Reagents, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 15: Hematology - Major Vendors
Slide 16: Microbiology - Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 17: Microbiology - Instruments, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e), Reagents, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 18: Blood Gas & Electrolyte - Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 19: Blood Gas & Electrolyte - Instruments, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e), Reagents, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 20: Molecular Diagnostics - Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 21: Molecular Diagnostics - Instruments, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e), Reagents, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 22: Urinalysis - Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 23: Urinalysis - Instruments, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e), Reagents, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 24: Coagulation Analysis - Market Overview, Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 25: Coagulation Analysis - Instruments, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e), Reagents, Market Overview and Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)

Drivers & Challenges 
Slide 26: In Vitro Diagnostic Market - Drivers and Challenges summary
Slide 27-33: Drivers
Slide 34-35: Challenges 
 
Laws and Guidelines
Slide 36-41: Overview of various Laws and Guidelines

Market Trends
Slide 42: Trends - Summary
Slide 43-47: Trends

Competitive Landscape
Slide 48: Porter's Five Forces Analysis
Slide 49-53: Competitive Benchmarking (FY 2013)
Slide 54-65: Major Public Players
Slide 66-122: Major Private Players

Future Outlook
Slide 123: Future Outlook Overview
Slide 124: Budget 2014 - 15 Overview

Strategic Recommendations
Slide 125- 126: Strategic Recommendations

 Appendix
Slide 127-128: Ratio and Calculations and Secondary Research

List of Tables
Market Overview
1. Major Vendors in Hematology Market
Laws and Guidelines
1. Categories of IVD by the Directive (on the basis of risk level)
2. Key Executive Members Of The Organization

Future Outlook
1. Measure and Impact of Budget 2014-15

Competitive Landscape
1. Public Trading Comparables
2. Company Profiles (All Companies)
a. Company Information (All Companies)
b. Products and Services (All Companies)
c. Key People (All Companies)
d. Shareholders of the Company (Private Companies)
e. Key Financial Performance Indicators (Public Companies)
f. Key Ratios (All Companies)
g. Business Highlights (All Companies)

Appendix
1. Key Ratio Descriptions
2. Secondary Research